Rehman, Fawad Ur’s team published research in Journal of Controlled Release in 2022-05-31 | 112-63-0

Journal of Controlled Release published new progress about Antibiotic resistance. 112-63-0 belongs to class esters-buliding-blocks, and the molecular formula is C19H34O2, Safety of (9Z,12Z)-Methyl octadeca-9,12-dienoate.

Rehman, Fawad Ur; Liu, Yang; Yang, Qingshan; Yang, Haoying; Liu, Runhan; Zhang, Dongya; Muhammad, Pir; Liu, Yanjie; Hanif, Sumaira; Ismail, Muhammad; Zheng, Meng; Shi, Bingyang published the artcile< Heme Oxygenase-1 targeting exosomes for temozolomide resistant glioblastoma synergistic therapy>, Safety of (9Z,12Z)-Methyl octadeca-9,12-dienoate, the main research area is glioblastoma synergistic therapy heme oxygenase exosome; Exosome; Glioblastoma; HMOX1; Temozolomide resistance; siRNA.

Glioblastoma (GBM) is a highly fatal and recurrent brain cancer without a complete prevailing remedy. Although the synthetic nanotechnol.-based approaches exhibit excellent therapeutic potential, the associated cytotoxic effects and organ clearance failure rest major obstacles from bench to clinics. Here, we explored allogeneic bone marrow mesenchymal stem cells isolated exosomes (BMSCExo) decorated with heme oxygenase-1 (HMOX1) specific short peptide (HSSP) as temozolomide (TMZ) and small interfering RNA (siRNA) nanocarrier for TMZ resistant glioblastoma therapy. The BMSCExo had excellent TMZ and siRNA loading ability and could traverse the blood-brain barrier (BBB) by leveraging its intrinsic brain accumulation property. Notably, with HSSP decoration, the TMZ or siRNA encapsulated BMSCExo exhibited excellent TMZ resistant GBM targeting ability both in vitro and in vivo due to the overexpression of HMOX1 in TMZ resistant GBM cells. Further, the HSSP decorated BMSCExo delivered the STAT3 targeted siRNA to the TMZ resistant glioma and restore the TMZ sensitivity, consequently achieved the synergistically drug resistant GBM treatment with TMZ. Our results showed this biomimetic nanoplatform can serve as a flexible, robust and inert system for GBM treatment, especially emphasizing the drug resistant challenge.

Journal of Controlled Release published new progress about Antibiotic resistance. 112-63-0 belongs to class esters-buliding-blocks, and the molecular formula is C19H34O2, Safety of (9Z,12Z)-Methyl octadeca-9,12-dienoate.

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics